Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
General Information
Revision date
2021-05-18
Product name
Pembrolizumab Solid Formulation
supplier name
Merck & Co., Inc
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
Merck & Co., Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@merck.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D, H372
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS classification in accordance with the OSHA Hazard Communication Standard (29 CFR 1910.1200) Combustible dust Reproductive toxicity Category 1B Specific target organ toxicity Category 1 (Immune system) - repeated exposure (Oral)
Signal word
Danger
Hazard statements
If small particles are generated during further processing, handling or by other means, may form combustible dust concentrations in air. H360D May damage the unborn child. H372 Causes damage to organs (Immune system) through prolonged or repeated exposure if swallowed.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves, protective clothing, eye protection and face protection.
Response
P308 + P313 IF exposed or concerned: Get medical attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents and container to an approved waste disposal plant.
2.3 Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin.
